The saga of PI3K inhibitors in haematological malignancies: survival is the ultimate safety endpoint

Affiliations

• ¹ Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: nicholas.richardson@fda.hhs.gov.
• ² Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
• ³ Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD 20993, USA.